Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2026-01-07 @ 5:45 PM
Study NCT ID:
NCT06847334
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-02-26
First Post:
2025-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX17 Vs. Keytruda® in the First-Line Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
Sponsor:
Shanghai Henlius Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-27
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-04-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-24
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-20
First Submit QC Date:
None
Study First Post Date:
2025-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-21
Last Update Post Date:
2025-02-26
Last Update Post Date Type:
ACTUAL